By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
When I sat down with Bahija Jallal at this year’s Bio International Conference in Chicago, the new leader of MedImmune surprised me with her sense of humor. I was telling her about my fondness for unique names and inquired as to the country of origin of “Bahija.” In a deadpan reply that even Carol Burnett would have been proud of, she stated, “It’s Swedish.” Laughing — because I actually bought it — Jallal went on to explain that she grew up in Morocco before studying in France and Germany and working on both the West and East Coasts of the United States. I quickly learned that Jallal thrives on change, something she experienced relatively quickly after joining MedImmune in as the VP of translational sciences.
Just one year into her position at the Maryland-based biotech, the company was acquired by AstraZeneca (AZ) for a whopping $ billion. Under her watch, Jallal guided MedImmune’s R&D biologics pipeline from 40 drugs to +. That track record didn’t go unnoticed by AZ’s newly appoint
ed CEO, Pascal Soriot. In what some de
Bahija Jallal: pharma’s Woman of the Year in a landmark 12 months
AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Woman of the Year for – in what turned out to be a watershed year for women’s rights. She joined HBA CEO Laurie Cooke at a meeting in London recently to reflect on how she made it to the top in pharma R&D – and how more can be done in pharma and biotech to promote gender equality.
The subject of gender equality and sexual harassment exploded into global consciousness in , largely due to the revelations around film producer Harvey Weinstein, and the subsequent #MeToo movement – an outpouring of testimony from women who have suffered from similar sexual harassment and discrimination.
This outrage has been harnessed by the #TimesUp campaign, which has re-energised debate in society about how to not only eliminate sexual harassment, but also to bring about equality in the workplace. That’s because despite progress over the last decade, gender parity in pay and women in senior board positions is still a distant goal in many organisations in the US and Europe.
The pharma industry is typical of thi
Protein Therapeutics, 2 Volume Set
Tristan Vaughan is Vice President, Research and Development for antibody discovery and protein engineering at MedImmune. Based in Cambridge (UK), Dr. Vaughan leads the work of scientists who are responsible for discovering and engineering around half of MedImmune's biologics portfolio, and who have delivered over 50 protein-based therapeutic candidates into the clinical phases of development. Dr. Vaughan joined MedImmune, previously Cambridge Antibody Technology, in and developed the platform technology which built the first human antibody libraries of 10 E10 members. He is also a key inventor of Humira and Benlysta. Dr. Vaughan has over 60 publications in peer-reviewed journals to his name.
Jane Osbourn is Vice President, Research and Development at MedImmune and Site Leader for MedImmune Cambridge (UK). An expert in antibody engineering, Dr. Osbourn joined MedImmune, formerly Cambridge Antibody Technology, in , and is an originator of key peer-reviewed publications and patents. She made a significant contribution to the discovery and development of marketed drugs (Humira and Benlysta) and more than 40 clinical candidates. Dr. Osbourn
Outpace Bio, a Leader in Protein Design & Cell Engineering, Adds Bahija Jallal to Board of Directors
Seattle, WA, March 23, (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced that Dr. Bahija Jallal has joined its Board of Directors. The move bolsters Outpace’s efforts to develop technologies that can reprogram how gene-modified cell therapies function and coordinate a productive immune response, yielding safe and effective cell therapies for cancer patients.
Bahija Jallal, CEO and Director of the Board of Immunocore, a commercial-stage biotechnology company oversaw the historic regulatory approval of the world’s first T cell receptor (TCR) therapy for a solid tumor. She brings deep R&D and company leadership experience to Outpace.
As President of MedImmune and Executive Vice President of AstraZeneca, Jallal led the development and approval of five new biologic medicines across three therapeutic areas, while boosting the company’s research & development pipeline and deal-making. Dr. Jallal serves on the Board of Elevance, Inc. and is a member of the Board of Trustees of Johns Hopkins U
Biographies you may also like
Seung heon song biography of martin Who is Song Seung-Heon? Song Seung-Heon is a famous Actor from South Korea. He got popular after playing the role of Yoon Joon-suh in the Korean drama Autumn in My Heart ().Missing: martin.
Mlk online biography for kids Martin Luther King Jr. Biography For Students: American Baptist minister, activist, humanitarian, and leader in the African-American Civil Rights Movement.
Sean lowe bachelor height Sean Lowe is an American television star best known for his role on ABC's The Bachelor season 17, which he earned a year after finishing third on Emily Maynard's season of .
Barack obama biography in short Facts and Info: Barack Obama is the 44th president of America and is the first African American to be elected president of the United States. His term in office started in The important .
Dan fisher oklahoma biography American politician; Republican member of the Oklahoma House of Representatives.
Ben bradlee and martha raddatz biography Her first marriage was to Ben Bradlee Jr., a journalist and author, with whom she had a son, Luke. This marriage ended in divorce, leading her to her second marriage with .